99 related articles for article (PubMed ID: 26416045)
41. Peroxisome proliferator-activated receptor gamma (PPARG) polymorphisms and breast cancer susceptibility: a meta-analysis.
Tang W; Chen Y; Wang Y; Gu H; Chen S; Kang M
Int J Clin Exp Med; 2015; 8(8):12226-38. PubMed ID: 26550133
[TBL] [Abstract][Full Text] [Related]
42. The association between VEGF -634C/G polymorphisms and osteonecrosis of femoral head: a meta-analysis.
Wang Y; Xia CJ; Wang BJ; Ma XW; Zhao DW
Int J Clin Exp Med; 2015; 8(6):9313-9. PubMed ID: 26309590
[TBL] [Abstract][Full Text] [Related]
43. Lack of any Association between the Hogg1 Ser326Cys Polymorphism and Breast Cancer Risk: a Systematic Review And Meta-Analysis Of 18 Studies.
Kamali M; Kargar S; Heiranizadeh N; Zare M; Kargar Sh; Zare Shehneh M; Neamatzadeh H
Asian Pac J Cancer Prev; 2017 Jan; 18(1):245-251. PubMed ID: 28240527
[TBL] [Abstract][Full Text] [Related]
44. Association between the rs1042522 polymorphism in
Fan S; Hao ZY; Zhang M; Liang CZ
Chronic Dis Transl Med; 2017 Jun; 3(2):95-104. PubMed ID: 29063062
[TBL] [Abstract][Full Text] [Related]
45. Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility.
Hu YY; Du XY; Zhan AL; Zhou L; Jiang Q; Niu YM; Shen M
Oncotarget; 2016 Jul; 7(30):47711-47719. PubMed ID: 27351225
[TBL] [Abstract][Full Text] [Related]
46. Association of Interleukin-10 Polymorphism (rs1800896, rs1800871, and rs1800872) With Breast Cancer Risk: An Updated Meta-Analysis Based on Different Ethnic Groups.
Li L; Xiong W; Li D; Cao J
Front Genet; 2022; 13():829283. PubMed ID: 35186043
[No Abstract] [Full Text] [Related]
47. Polymorphism of vascular endothelial growth factor -1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies.
Hong TT; Zhang RX; Wu XH; Hua D
Mol Biol Rep; 2012 May; 39(5):5283-9. PubMed ID: 22167330
[TBL] [Abstract][Full Text] [Related]
48. The single nucleotide polymorphism +936 C/T VEGF is associated with human epidermal growth factor receptor 2 expression in Moroccan breast cancer women.
Rahoui J; Sbitti Y; Touil N; Laraqui A; Ibrahimi A; Rhrab B; Al Bouzidi A; Moussaoui Rahali D; Dehayni M; Ichou M; Zaoui F; Mrani S
Med Oncol; 2014 Dec; 31(12):336. PubMed ID: 25412937
[TBL] [Abstract][Full Text] [Related]
49. Assessment of the associations between three VEGF polymorphisms and risk of prostate cancer.
Chen GQ; Luo JB; Wang GZ; Ding JE
Tumour Biol; 2014 Mar; 35(3):1875-9. PubMed ID: 24353087
[TBL] [Abstract][Full Text] [Related]
50. Lack of association of the cyclooxygenase-2 gene 8473T>C polymorphism with breast cancer risk: a meta-analysis.
Yang X; Zhao F; Li YH; Huang M; Huang Y; Yi C
Asian Pac J Cancer Prev; 2014; 15(22):9693-8. PubMed ID: 25520090
[TBL] [Abstract][Full Text] [Related]
51. Polymorphism of 8q24 rsl3281615 and breast cancer risk : a meta-analysis.
Pei YL; Zhang HL; Han HG
Tumour Biol; 2013 Feb; 34(1):421-8. PubMed ID: 23132293
[TBL] [Abstract][Full Text] [Related]
52. Current evidence on VEGF+405G/C polymorphism and malignancy susceptibility: a meta-analysis involving 30 studies.
Hu K; Zhang Y; Wang R; Li G; Li G; Zhang D
Twin Res Hum Genet; 2012 Aug; 15(4):496-502. PubMed ID: 22853925
[TBL] [Abstract][Full Text] [Related]
53. Association between VEGF -634G/C polymorphism and susceptibility to autoimmune diseases: a meta-analysis.
Chen H; Zhang T; Gong B; Cao X
Gene; 2015 Mar; 558(2):181-6. PubMed ID: 25596346
[TBL] [Abstract][Full Text] [Related]
54. Vascular endothelial growth factor gene polymorphism (-634G/C) and breast cancer risk.
Yao W; Yan R; Ma L; Wan H; Yu Y; Cheng X; Li Y
Tumour Biol; 2014 Aug; 35(8):7793-8. PubMed ID: 24816918
[TBL] [Abstract][Full Text] [Related]
55. Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies.
Qin Q; Zhang C; Zhu H; Yang X; Xu L; Liu J; Lu J; Zhan L; Cheng H; Sun X
J Cancer Res Clin Oncol; 2014 Feb; 140(2):179-88. PubMed ID: 24077840
[TBL] [Abstract][Full Text] [Related]
56. Association of PD-L1 gene rs4143815 C>G polymorphism and human cancer susceptibility: A systematic review and meta-analysis.
Zou J; Wu D; Li T; Wang X; Liu Y; Tan S
Pathol Res Pract; 2019 Feb; 215(2):229-234. PubMed ID: 30552042
[TBL] [Abstract][Full Text] [Related]
57. Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk.
Zhou JQ; Kang XL; Wang Y; Xu CJ
Technol Cancer Res Treat; 2017 Dec; 16(6):978-986. PubMed ID: 28593813
[TBL] [Abstract][Full Text] [Related]
58. CD243 gene polymorphism significantly associated with breast cancer susceptibility.
Yao W; Yan R; Ma L; Wan H; Yu Y; Cheng X; Li Y
Tumour Biol; 2014 Aug; 35(8):8017-22. PubMed ID: 24839009
[TBL] [Abstract][Full Text] [Related]
59. Quantitative Assessment of the Effects of IL-1ß -511 C>T Variant on Breast Cancer Risk: An Updated Meta-Analysis of 3331 Cases and 3609 Controls.
Harati-Sadegh M; Mohammadoo-Khorasani M; Sargazi S; Saravani R; Shahraki S; Eskandari E
Lab Med; 2021 Jan; 52(1):36-46. PubMed ID: 32754752
[TBL] [Abstract][Full Text] [Related]
60. Association Between the
Zhao L; Yin XX; Qin J; Wang W; He XF
Front Genet; 2022; 13():807466. PubMed ID: 35571038
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
